Pyrrolidinone anilines as progesterone receptor modulators
申请人:GlaxoSmithKline LLC
公开号:US07816395B2
公开(公告)日:2010-10-19
The present invention relates to a compound represented by the following formula:
or a pharmaceutically acceptable salt thereof, or a solvate thereof, or a combination thereof, wherein R1, R2, and X are as defined herein. Compounds of the present invention are useful as progesterone receptor modulators.
[EN] PYRROLIDINONE ANILINES AS PROGESTERONE RECEPTOR MODULATORS<br/>[FR] PYRROLIDINONE ANILINES UTILISÉES EN TANT QUE MODULATEURS DU RÉCEPTEUR DE LA PROGESTÉRONE
申请人:SMITHKLINE BEECHAM CORP
公开号:WO2008021796A2
公开(公告)日:2008-02-21
[EN] The present invention relates to a compound represented by the following formula (I):or a pharmaceutically acceptable salt thereof, or a solvate thereof, or a combination thereof, wherein R1, R2, and X are as defined herein. Compounds of the present invention are useful as progesterone receptor modulators. [FR] La présente invention concerne un composé représenté par la formule (I) suivante : ou un sel ou un solvate pharmaceutiquement acceptable de ce composé, ou leur combinaison, R1, R2, et X étant tels que définis dans ce document. Les composés de la présente invention se révèlent utiles en tant que modulateurs du récepteur de la progesterone.
PYRROLIDINONE ANILINES AS PROGESTERONE RECEPTOR MODULATORS
申请人:WASHBURN David G.
公开号:US20080039517A1
公开(公告)日:2008-02-14
The present invention relates to a compound represented by the following formula:
or a pharmaceutically acceptable salt thereof, or a solvate thereof, or a combination thereof, wherein R
1
, R
2
, and X are as defined herein. Compounds of the present invention are useful as progesterone receptor modulators.